Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. Materials and Methods: In this retrospective study we analyzed patients with positive polymerase chain reaction test in tertiary care hospital between March-May 2020. They were divided into 3 groups according to body mass index (BMI) as normal, overweight, and obese (BMI: 18.5 - 24.99 kg/m2 , 25 - 29.99 kg/m2 , and ≥ 30 kg/m2 , respectively). We compared clinical features and laboratory findings of these groups and recorded adverse clinical outcomes. Multivariate logistic analysis was performed for unfavorable outcomes. Results: There were 99 patients (35%), 116 (41%), and 69 patients (24%) in the normal-weight, overweight, and obese group, respectively. Among all patients, 52 (18%) patients were transferred to the intensive care unit (ICU), 30 (11%) patients received invasive mechanical ventilation (IMV), and 22 patients (8%) died. Obese patients had minimum 1 more comorbidity than normal BMI patients (73% vs. 50%, P = 0.002), and a longer median (interquartile range [IQR]) duration of hospitalization (8 [5 - 12] vs. 6 [5 - 9]) days, P = 0.006). Obese participants had higher concentrations of serum C-reactive protein, procalcitonin, ferritin than nonobese patients (P <0.05 in all). In a multivariate analysis, obesity was associated with ICU admission (adjusted odds ratio [aOR]: 2.99, 95% confidence interval [CI]: 1.26 - 7.04, P = 0.012). Moreover, IMV requirement was associated with obesity (aOR: 8.73, 95% CI: 2.44 - 31.20, P = 0.001). Mortality occurred in 16%, 9%, and 1% of the obese group, overweight group, and normal-weight group, respectively (Chi-square trend analysis, P = 0.002). Conclusion: Obesity is a risk factor for adverse outcomes and caused increased mortality, hence requiring close follow-up.
Abstract
Background: Coronavirus disease 2019 (COVID-19) continues to cause major mortality and morbidity worldwide even after a year of its emergence. In its early days, hypertension, diabetes, and cardiovascular diseases were noted as poor prognostic factors, while obesity gained attention at a later stage. In the present study, unfavorable clinical outcomes (transfer to the intensive care unit, invasive mechanical ventilation, and mortality) were investigated in obese patients with COVID-19. Materials and Methods: In this retrospective study we analyzed patients with positive polymerase chain reaction test in tertiary care hospital between March-May 2020. They were divided into 3 groups according to body mass index (BMI) as normal, overweight, and obese (BMI: 18.5 - 24.99 kg/m2 , 25 - 29.99 kg/m2 , and ≥ 30 kg/m2 , respectively). We compared clinical features and laboratory findings of these groups and recorded adverse clinical outcomes. Multivariate logistic analysis was performed for unfavorable outcomes. Results: There were 99 patients (35%), 116 (41%), and 69 patients (24%) in the normal-weight, overweight, and obese group, respectively. Among all patients, 52 (18%) patients were transferred to the intensive care unit (ICU), 30 (11%) patients received invasive mechanical ventilation (IMV), and 22 patients (8%) died. Obese patients had minimum 1 more comorbidity than normal BMI patients (73% vs. 50%, P = 0.002), and a longer median (interquartile range [IQR]) duration of hospitalization (8 [5 - 12] vs. 6 [5 - 9]) days, P = 0.006). Obese participants had higher concentrations of serum C-reactive protein, procalcitonin, ferritin than nonobese patients (P <0.05 in all). In a multivariate analysis, obesity was associated with ICU admission (adjusted odds ratio [aOR]: 2.99, 95% confidence interval [CI]: 1.26 - 7.04, P = 0.012). Moreover, IMV requirement was associated with obesity (aOR: 8.73, 95% CI: 2.44 - 31.20, P = 0.001). Mortality occurred in 16%, 9%, and 1% of the obese group, overweight group, and normal-weight group, respectively (Chi-square trend analysis, P = 0.002). Conclusion: Obesity is a risk factor for adverse outcomes and caused increased mortality, hence requiring close follow-up.
참고문헌 (31)
- "Novel coronavirus (2019-nCoV): situation report-11"[URL]
- "Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update"[URL]
- "Republic of Turkey Ministry: COVID-19 information page"[URL]
- Wu Z, "Characteristics of and Important lessons from the coronavirus disease 2019(COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention", JAMA, 323, pp.1239~1242 (2020)
- Yang J, "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis", Int J Infect Dis, 94, pp.91~95 (2020)
- Nakeshbandi M, "The impact of obesity on COVID-19 complications: a retrospective cohort study", Int J Obes (Lond), 44, pp.1832~1837 (2020)
- Lighter J, "Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission", Clin Infect Dis, 71, pp.896~897 (2020)
- Fezeu L, "Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis", Obes Rev, 12, pp.653~659 (2011)
- "Obesity and overweight"[URL]
- Cai Q, "Obesity and COVID-19 severity in a designated hospital in Shenzhen, China", Diabetes Care, 43, pp.1392~1398 (2020)
- Gao F, "Obesity is a risk factor for greater COVID-19 severity", Diabetes Care, 43, pp.e72~e74 (2020)
- Simonnet A, "High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Requiring invasive mechanical ventilation", Obesity (Silver Spring), 28, pp.1195~1199 (2020)
- Petrilli CM, "Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study", BMJ, 369, pp.m1966~ (2020)
- Moriconi D, "Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding", Obes Res Clin Pract, 14, pp.205~209 (2020)
- Wu J, "Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)", J Intern Med, 288, pp.128~138 (2020)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- "Directorate general of public health. COVID-19 (SARS-CoV-2infection) guide"[URL]
- Sanchis-Gomar F, "Obesity and outcomes in COVID-19: when an epidemic and pandemic collide", Mayo Clin Proc, 95, pp.1445~1453 (2020)
- Ramalingam L, "The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance", Biochim Biophys Acta Mol Basis Dis, 1863, pp.1106~1114 (2017)
- Kruglikov IL, "The role of adipocytes and adipocyte-like cells in the severity of COVID-19infections", Obesity (Silver Spring), 28, pp.1187~1190 (2020)
- Sung HK, "Korea National Committee for clinical management of COVID-19. Clinical course and outcomes of 3,060 patients with coronavirus disease 2019 in Korea, January-May 2020", J Korean Med Sci, 35, pp.e280~ (2020)
- León-Pedroza JI, "Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice", Cir Cir, 83, pp.543~551 (2015)
- Martí A, "Obesity and immune function relationships", Obes Rev, 2, pp.131~140 (2001)
- Huttunen R, "Obesity and the risk and outcome of infection", Int J Obes (Lond), 37, pp.333~340 (2013)
- Walsh JS, "Vitamin D in obesity", Curr Opin Endocrinol Diabetes Obes, 24, pp.389~394 (2017)
- Ashburn DD, "Pulmonary system and obesity", Crit Care Clin, 26, pp.597~602 (2010)
- Neidich SD, "Increased risk of influenza among vaccinated adults who are obese", Int J Obes, 41, pp.1324~1330 (2017)
- Ryan DH, "COVID 19 and the Patient with Obesity - The Editors Speak Out", Obesity (Silver Spring), 28, pp.847~ (2020)
- Malik P, "Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis", J Med Virol, 93, pp.1188~1193 (2021)
- Kang Hyun Mi, "The Impact of the Coronavirus Disease-2019 Pandemic on Childhood Obesity and Vitamin D Status", Journal of Korean Medical Science, 36(3), pp.1~11 (2021), 대한의학회[DOI]
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review", JAMA, 324, pp.782~793 (2020)